Medical Condition News

RSS

One in ten Europe's middle-aged citizens took antidepressants during 2010

New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.

20 Jun 2011

Study: Dyslexia gene controls cilia in brain neurons

Scientists at Karolinska Institutet in Sweden have discovered that a gene linked to dyslexia has a surprising biological function: it controls cilia, the antenna-like projections that cells use to communicate.

20 Jun 2011

Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

A single gene is central in the development of several forms of polycystic kidney and liver disease, Yale School of Medicine researchers report in the June 19 issue of Nature Genetics.

20 Jun 2011

University of Texas professor recommends three postulates to find probable cause of AD

After more than 100 years following its pathologic description, the cause of Alzheimer's disease (AD) remains unknown. To test the validity of present and future proposals related to the probable cause of AD, three postulates, or necessary conditions, are recommended by Jack de la Torre, MD, PhD, Adjunct Professor of Psychology at the University of Texas, Austin, in an article published in the Journal of Alzheimer's Disease.

20 Jun 2011

News media and childhood obesity

Where you get your news could play a significant role in determining what you perceive as the best strategy for addressing childhood obesity. According to a study led by researchers from the Johns Hopkins Bloomberg School of Public Health, whether you believe the keys to combating childhood obesity are personal factors such as individual behavior changes or system-level factors such as marketing and the environment may depend on your primary news source.

20 Jun 2011

Novel biomarker-development pipeline approach for human diseases

Researchers at Fred Hutchinson Cancer Research Center have demonstrated in mice that the performance of a novel biomarker-development pipeline using targeted mass spectrometry is robust enough to support the use of an analogous approach in humans.

20 Jun 2011

NOCSAE receives $1.1M research grants to advance science of sports medicine

The National Operating Committee on Standards for Athletic Equipment (NOCSAE) awarded $1.1 million in research grants to advance the science of sports medicine – specifically related to concussion.

20 Jun 2011

Zilver PTX stent more effective than PTA for treatment of femoral artery lesions

Results of a prospective, randomized trial indicate that when treating femoral artery (SFA) lesions, the Zilver PTX Paclitaxel-Eluting Stent shows sustained effectiveness compared to percutaneous transluminal angioplasty, even in diabetic patients.

20 Jun 2011

New study: 8% of children have food allergies

A new study in Pediatrics finds 8 percent of children have food allergies, much higher that previously reported.

20 Jun 2011

Positive results from vismodegib Phase II study on advanced basal cell carcinoma

Genentech, a member of the Roche Group, announced today that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.

20 Jun 2011

Surgeons demonstrate potential genetic basis for varying outcomes of leg vein bypass surgery

Vascular Cures, a leading non-profit investing in research to develop breakthrough treatments for vascular disease, announced results that indicate there may be a genetic basis for the varying outcomes of bypass surgery in the legs.

20 Jun 2011

Study: Hospital-wide program holds promise against venous thromboembolic events

Implementation and early results of a hospital-wide program hopes to reduce the incidence of venous thromboembolic events (VTE), according to a study presented today at the 65th Vascular Annual Meeting presented by the Society for Vascular Surgery.

20 Jun 2011

Novel vaccine approach for prostate cancer

Mayo Clinic investigators and collaborators from the United Kingdom cured well-established prostate tumors in mice using a human vaccine with no apparent side effects. This novel cancer treatment approach encourages the immune system to rid itself of prostate tumors without assistance from toxic chemotherapies and radiation treatments.

20 Jun 2011

Disclosing sexual identity increases emotional well-being, but mainly in supportive settings

Coming out as lesbian, gay, or bisexual increases emotional well-being even more than earlier research has indicated. But the psychological benefits of revealing one's sexual identity -- less anger, less depression, and higher self-esteem - are limited to supportive settings, shows a study published June 20 in Social Psychology and Personality Science.

20 Jun 2011

Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.

20 Jun 2011

Researchers use DNA library to create potential cancer vaccine

University of Leeds researchers, funded by Cancer Research UK, have used a library of DNA to create a vaccine that could be used to treat cancer, according to a study published in Nature Medicine.

20 Jun 2011

Scientists discover linchpin protein that drives mitochondria's calcium machinery

Mitochondria, those battery-pack organelles that fuel the energy of almost every living cell, have an insatiable appetite for calcium. Whether in a dish or a living organism, the mitochondria of most organisms eagerly absorb this chemical compound.

20 Jun 2011

Scientists discover three susceptibility genes for development of progressive supranuclear palsy

An international research team, co-led by scientists at Mayo Clinic's campus in Florida, have discovered three potential susceptibility genes for development of progressive supranuclear palsy (PSP), a rare neurodegenerative disease that causes symptoms similar to those of Parkinson's disease but is resistant to Parkinson's medications.

20 Jun 2011

GRACE, LUNGevity announce free webinar program to highlight lung cancer research

LUNGevity Foundation and GRACE announce a free webinar program to provide the highlights in lung cancer research from the American Society for Clinical Oncology (ASCO) Annual Meeting held June 3-6, 2011 in Chicago.

20 Jun 2011

New insight into progressive supranuclear palsy

There are new genetic clues on risk factors and biological causes of a rare neurodegenerative disease called progressive supranuclear palsy (PSP), according to a new study from an international genetics team led by researchers from the Perelman School of Medicine at the University of Pennsylvania.

20 Jun 2011

Medical Condition News

One in ten Europe's middle-aged citizens took antidepressants during 2010

Study: Dyslexia gene controls cilia in brain neurons

Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

University of Texas professor recommends three postulates to find probable cause of AD

News media and childhood obesity

Novel biomarker-development pipeline approach for human diseases

NOCSAE receives $1.1M research grants to advance science of sports medicine

Zilver PTX stent more effective than PTA for treatment of femoral artery lesions

New study: 8% of children have food allergies

Positive results from vismodegib Phase II study on advanced basal cell carcinoma

Surgeons demonstrate potential genetic basis for varying outcomes of leg vein bypass surgery

Study: Hospital-wide program holds promise against venous thromboembolic events

Novel vaccine approach for prostate cancer

Disclosing sexual identity increases emotional well-being, but mainly in supportive settings

Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011

Researchers use DNA library to create potential cancer vaccine

Scientists discover linchpin protein that drives mitochondria's calcium machinery

Scientists discover three susceptibility genes for development of progressive supranuclear palsy

GRACE, LUNGevity announce free webinar program to highlight lung cancer research

New insight into progressive supranuclear palsy

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News